Édouard Bruc focuses primarily on antitrust and competition law, as well as related litigation.

Mr. Bruc represents clients in abuse of dominance and cartel proceedings before the European Commission. He also has experience in state aid, especially in tax ruling cases. He has a deep interest in unilateral conduct cases, class actions, intellectual property rights and due process issues in antitrust enforcement. His practice covers a broad range of industries, including pharmaceutical, transport, digital, telecommunications, electricity and gas, and financial services.

Recently, he was part of the team that negotiated Phase I merger clearance remedies in a significant acquisition in the biopharma sector. Following the EU’s Trucks cartel decision, Mr. Bruc also assisted clients from various jurisdictions in the context of an EU-wide billion-euro class action before the Amsterdam Court. He has worked on cases before various national regulatory authorities (CMA, Autorité de la concurrence, AMF, ARCEP and CRE) as well as the Court of Justice of the European Union in Luxembourg. 

Mr. Bruc is also particularly interested in pro-bono work concerning freedom of press, freedom of speech or privacy, and mass surveillance issues. 

Prior to joining WilmerHale, Mr. Bruc worked in the antitrust practice of other leading international law firms in Paris and London. 


  • Cartels

    • Advising clients regarding a multi-billion-euro follow-on claim in the transport sector 
    • Advising a franchisor on vertical restraints (RPM, non-compete, etc.) within its network 
    • Assessing settlement procedures in several EU countries (France, Germany, Spain, UK, etc.)
  • Abuse of Dominance

    • Advising a client on excessive pricing rules in the pharmaceutical sector
    • Advising a client on the risk of market partitioning in the pharmaceutical sector
  • State Aid

    • Advising a client in connection with litigation involving tax rulings
  • Merger Control

    • Advising Danaher Corporation concerning its acquisition of GE Life Sciences’ Biopharma business for approximately $21.4 billion and the subsequent divestments to Sartorius
  • Electronic Communications & Energy

    • Advising a client and claiming damages regarding an unfair commercial practice involving a leading tech company in the telecommunication sector
    • Advising a client regarding the impact of further liberalization of the energy sector
    • Advising an incumbent firm regarding a follow-on claim in the overseas communication sector
  • Transport

    • Assessing the impact of the fourth European package in the rail sector

Insights & News


  • Education

    • LLM, Competition Law, Queen Mary University of London, School of Law, 2017

    • LLM, Competition, Corporate and Tax Law, University of Montpellier, 2016

    • Magister, Juriste d’Affaires, DJCE Montpellier, 2013–2016

  • Admissions

    • Brussels (associate member)

    • Paris

  • Languages

    • English

    • French